Literature DB >> 10639707

Delivery of a normal newborn after intensive medical treatment for an acute exacerbation of ulcerative colitis during pregnancy: a case report.

N Ishijima1, E Ojima, H Tonouchi, H Suzuki, S Fukunishi.   

Abstract

A 28-year-old woman developed an acute exacerbation of chronic ulcerative colitis in the second trimester of pregnancy. She was treated by intensive medical treatment with intravenous prednisolone, betamethasone enema, oral salazosulfapyridine, intravenous ceftazitim, and total parenteral nutrition. The acute relapse subsided after 73 days of the treatment and a normal female newborn weighing 2,208 g was delivered vaginally after 40 weeks' gestation. Our experience showed that the intensive medical therapy did not impair either the course of the pregnancy or the fetal outcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10639707     DOI: 10.1007/BF02482218

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

Review 1.  Total parenteral nutrition during pregnancy.

Authors:  R V Lee; B D Rodgers; C Young; E Eddy; J Cardinal
Journal:  Obstet Gynecol       Date:  1986-10       Impact factor: 7.661

2.  Total parenteral nutrition in pregnancy.

Authors:  C G Hatjis; P J Meis
Journal:  Obstet Gynecol       Date:  1985-10       Impact factor: 7.661

3.  Total parenteral nutrition in pregnancy: conception to delivery.

Authors:  F W Nugent; M Rajala; R A O'Shea; P F Kolack; M A Hobin; M K Haimes; M L Ingalls
Journal:  JPEN J Parenter Enteral Nutr       Date:  1987 Jul-Aug       Impact factor: 4.016

Review 4.  Drug therapy for ulcerative colitis during pregnancy.

Authors:  R Modigliani
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-09       Impact factor: 2.566

5.  Total parenteral nutrition in pregnancy complicated by Crohn's disease.

Authors:  L B Jacobson; D H Clapp
Journal:  JPEN J Parenter Enteral Nutr       Date:  1987 Jan-Feb       Impact factor: 4.016

Review 6.  Inflammatory bowel disease and pregnancy.

Authors:  R J Vender; H M Spiro
Journal:  J Clin Gastroenterol       Date:  1982-06       Impact factor: 3.062

7.  Fulminant ulcerative colitis in pregnancy.

Authors:  R Boulton; M Hamilton; A Lewis; P Walker; R Pounder
Journal:  Am J Gastroenterol       Date:  1994-06       Impact factor: 10.864

Review 8.  Inflammatory bowel disease presenting in pregnancy.

Authors:  M R Morton
Journal:  Aust N Z J Obstet Gynaecol       Date:  1992-02       Impact factor: 2.100

9.  The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.

Authors:  P J Baiocco; B I Korelitz
Journal:  J Clin Gastroenterol       Date:  1984-06       Impact factor: 3.062

10.  Total parenteral nutrition for the treatment of severe hyperemesis gravidarum: maternal nutritional effects and fetal outcome.

Authors:  M G Levine; D Esser
Journal:  Obstet Gynecol       Date:  1988-07       Impact factor: 7.661

View more
  5 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

Review 2.  Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literature.

Authors:  A I Haq; A Sahai; S Hallwoth; D S Rampton; S Dorudi
Journal:  Int J Colorectal Dis       Date:  2005-08-20       Impact factor: 2.571

Review 3.  Gastrointestinal endoscopy in pregnancy.

Authors:  Nurten Savas
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Challenges in management of gastrointestinal cancers in pregnancies: A report of three cases.

Authors:  Serene Thain; Jess McMicking; Julien de Naurois; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2021-03-09

Review 5.  Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? - a systematic review.

Authors:  Alison De Lima; Boris Galjart; Pieter H A Wisse; Wichor M Bramer; C Janneke van der Woude
Journal:  BMC Gastroenterol       Date:  2015-02-12       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.